With the median age of diagnosis being approximately 70 years, chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the U.S. At the present time, most patients have a period of observation before therapy initiation. During the treatment naïve period, normal immune functions are impaired, increasing the risk of secondary malignancies and infections. Most people who are 70 wouldn’t call themselves geriatric, but patients in this stage often have low physical fitness that predicts poor survival following commencement of treatment.
During this program we will talk to a CLL expert about concurrently improving physical fitness and immune functions by participating in a structured exercise program. We will talk with another CLL expert about fixed-duration chemotherapy-free regimens for frail patients in the treatment naïve period. Tune in to learn more!
Support for this series has been provided by AbbVie, Inc. and Genentech, Inc. Patient power maintains complete editorial control and is solely responsible for program content.
Hosts and Guests
Bita Fakhri MD, MPH
Hematologist-oncologist & Assistant Professor, UCSF Helen Diller Family Comprehensive Cancer Center
Andrea Sitlinger MD
Hematologist-Oncologist, Duke Cancer Institute